
Autolus Therapeutics plc AUTL
€ 1.22
-0.35%
Geschäftsbericht 2025
hinzugefügt 27.03.2026
Autolus Therapeutics plc EV/EBITDA 2011-2026 | AUTL
EV/EBITDA Jährlich Autolus Therapeutics plc
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.38 | -1 | -1.59 | -11.2 | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -1 | -11.2 | -3.79 |
EV/EBITDA anderer Aktien in der Pharmaeinzelhändler
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Anavex Life Sciences Corp.
AVXL
|
-12 | $ 3.02 | 1.0 % | $ 258 M | ||
|
MorphoSys AG
MOR
|
-0.591 | - | 2.43 % | $ 254 M | ||
|
BioNTech SE
BNTX
|
4.1 | $ 90.9 | -0.31 % | $ 27.2 B | ||
|
BioLineRx Ltd.
BLRX
|
-53.5 | $ 2.34 | 5.72 % | $ 908 M | ||
|
I-Mab
IMAB
|
595 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
10.7 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
4.22 K | - | 2.54 % | $ 160 B | ||
|
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M | ||
|
Midatech Pharma plc
MTP
|
0.796 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.42 | - | -1.52 % | $ 24.7 M | ||
|
Codexis
CDXS
|
-100 | $ 1.93 | 6.04 % | $ 168 M | ||
|
Cerus Corporation
CERS
|
-24.7 | $ 1.9 | 1.88 % | $ 362 M | ||
|
Acorda Therapeutics
ACOR
|
0.777 | - | -24.86 % | $ 820 K | ||
|
Cullinan Management
CGEM
|
-8.81 | $ 15.2 | 5.34 % | $ 916 M | ||
|
Adverum Biotechnologies
ADVM
|
-1.32 | - | - | $ 86.2 M | ||
|
Advaxis
ADXS
|
-82.4 | - | -9.65 % | $ 45.9 M | ||
|
Coherus BioSciences
CHRS
|
-4.11 | $ 1.69 | -2.31 % | $ 198 M | ||
|
Applied Molecular Transport
AMTI
|
-1.19 | - | - | $ 10.1 M | ||
|
Aeterna Zentaris
AEZS
|
4.4 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
-1.85 | - | -10.17 % | $ 12.2 K | ||
|
AIkido Pharma
AIKI
|
-45.5 | - | 1.93 % | $ 17.4 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-4.27 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.546 | - | - | $ 26.5 M | ||
|
Akero Therapeutics
AKRO
|
-4.64 | - | - | $ 3.67 B | ||
|
Akouos
AKUS
|
-1.13 | - | 0.23 % | $ 488 M | ||
|
Институт стволовых клеток человека
ISKJ
|
14 | - | - | - | ||
|
CollPlant Biotechnologies Ltd.
CLGN
|
190 | $ 0.46 | -13.46 % | $ 5.27 M | ||
|
Allena Pharmaceuticals
ALNA
|
0.298 | - | 3.16 % | $ 1.9 M | ||
|
Alpine Immune Sciences
ALPN
|
-5.5 | - | - | $ 2.17 B | ||
|
Aileron Therapeutics
ALRN
|
-0.0369 | - | 10.36 % | $ 9.8 M | ||
|
Aquestive Therapeutics
AQST
|
-7.26 | $ 4.11 | -0.48 % | $ 439 M | ||
|
CNS Pharmaceuticals
CNSP
|
0.205 | $ 2.27 | 0.39 % | $ 1.01 M | ||
|
Catalyst Pharmaceuticals
CPRX
|
7.16 | $ 24.91 | 0.89 % | $ 3.05 B | ||
|
Aravive
ARAV
|
-0.158 | - | -13.39 % | $ 1.45 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
-2.37 | $ 8.3 | 3.36 % | $ 227 M | ||
|
Corbus Pharmaceuticals Holdings
CRBP
|
-0.248 | $ 10.37 | 1.97 % | $ 138 M | ||
|
Cardiff Oncology
CRDF
|
-8.15 | $ 1.6 | 0.95 % | $ 107 M | ||
|
Curis
CRIS
|
-7.31 | $ 0.53 | -3.64 % | $ 6.98 M | ||
|
Crinetics Pharmaceuticals
CRNX
|
-8.38 | $ 38.09 | 2.31 % | $ 3.58 B | ||
|
CRISPR Therapeutics AG
CRSP
|
13.1 | $ 49.43 | -0.17 % | $ 4.44 B | ||
|
Aptose Biosciences
APTO
|
388 | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
-1.56 | - | -39.0 % | $ 4.57 M | ||
|
CytomX Therapeutics
CTMX
|
-3.71 | $ 4.41 | -3.4 % | $ 608 M | ||
|
Citius Pharmaceuticals
CTXR
|
-2.05 | $ 0.87 | 1.26 % | $ 5.85 M | ||
|
Cue Biopharma
CUE
|
-7.01 | $ 0.17 | -7.12 % | $ 16.1 M | ||
|
CureVac N.V.
CVAC
|
-7.74 | - | - | $ 867 M | ||
|
AstraZeneca PLC
AZN
|
76.5 | - | - | $ 96.9 B | ||
|
Celldex Therapeutics
CLDX
|
0.185 | $ 31.43 | 1.18 % | $ 2.09 B | ||
|
Cyclerion Therapeutics
CYCN
|
0.271 | $ 4.34 | -29.51 % | $ 10.9 M | ||
|
Avenue Therapeutics
ATXI
|
0.871 | - | -52.27 % | $ 4.45 M |